EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® ...

Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...

Teva Pharmaceuticals and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the randomised Phase IIb RELIEVE UCCD trial of human ...

Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...

The Australian company, which manufactures its footwear in Australia and just celebrated its 50th anniversary, owns the “UGG ...

As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...

Deckers Outdoor Corp., a U.S. footwear designer and distributor, has waged a protracted legal battle against companies around ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Here is what we know about KDC/ONE and where the shooting unfolded Tuesday. KDC/ONE is an international manufacturer of beauty, home care and personal care products. The company creates products ...

Teva Pharma Industries Ltd ADR (NYSE ... and 15% YoY in international markets. Global sales of its brand drugs were robust. AUSTEDO exceeded $1.6 billion in revenues, surpassing the company ...

A manufacturer that has been a fixture in Southington for almost 160 years is to close its Plantsville facility, with the loss of 103 jobs, after it was dropped by a key customer. Rex Forge says ...